Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
44
Number of overlapping holdings
21.9%
% of IBB's 219 holdings also in WDNA
49.4%
% of WDNA's 91 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 8.1% | 1.3% | 1.3% |
|
REGENERON PHARMACEUTICALS | 8.2% | 1.2% | 1.2% |
|
SAREPTA THERAPEUTICS INC | 1.1% | 1.1% | 1.1% |
|
AMGEN INC | 8.3% | 1.1% | 1.1% |
|
NATERA INC | 1.1% | 1.9% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to WDNA
|
GILEAD SCIENCES INC | 7.2% |
|
AMGEN INC | 7.1% |
|
REGENERON PHARMACEUTICALS | 7.0% |
|
VERTEX PHARMACEUTICALS INC | 6.8% |
|
IQVIA HOLDINGS INC | 4.4% |
|
MODERNA, INC. | 2.9% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.8% |
|
BIOGEN IDEC INC | 2.2% |
|
WATERS CORP | 2.0% |
 |
ARGENX SE ADR | 2.0% |
IBB Underweight Relative to WDNA
|
IOVANCE BIOTHERAPEUTICS INC | -3.6% |
|
TWIST BIOSCIENCE CORP. | -3.2% |
|
FATE THERAPEUTICS INC | -3.1% |
 |
NOVOZYMES A/S-B SHARES | -2.4% |
|
ELI LILLY & CO | -1.9% |
|
BRIDGEBIO PHARMA, INC. | -1.6% |
|
BLUEPRINT MEDICINES CORP. | -1.6% |
|
CARIBOU BIOSCIENCES, INC. | -1.6% |
 |
ALCOBRA LTD | -1.6% |
|
EDITAS MEDICINE, INC. | -1.6% |